Literature DB >> 19188060

Intravenous dexmedetomidine as an adjunct for labor analgesia and cesarean delivery anesthesia in a parturient with a tethered spinal cord.

A Palanisamy1, R J Klickovich, M Ramsay, D W Ouyang, L C Tsen.   

Abstract

For parturients desiring labor analgesia who have contraindications to neuraxial techniques, intravenous opioid-based patient-controlled analgesia (IVPCA) offers a reasonable alternative, although incomplete analgesia and maternal and neonatal respiratory depression can occur. Dexmedetomidine, a highly selective alpha(2) agonist with negligible placental transfer, may be a valuable adjunct to IVPCA by providing additional analgesia without the respiratory depression associated with increasing opioid usage. The successful use of a dexmedetomidine infusion as an adjunct to unsatisfactory fentanyl IVPCA is reported in a 31-year-old parturient with spina bifida occulta and a tethered spinal cord reaching L5-S1. Dexmedetomidine significantly improved the analgesic quality; increased sedation was observed, but the patient was easily rousable to verbal stimuli. No episodes of maternal hypotension or bradycardia, or fetal heart rate irregularities occurred. Cesarean delivery was required for prolonged first stage of labor and presumed chorioamnionitis; it was conducted under general anesthesia during which the dexmedetomidine infusion was continued. A healthy baby boy was delivered with normal Apgar scores and no discernible neurobehavioral or other deficits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188060     DOI: 10.1016/j.ijoa.2008.10.002

Source DB:  PubMed          Journal:  Int J Obstet Anesth        ISSN: 0959-289X            Impact factor:   2.603


  19 in total

1.  Should We Use Dexmedetomidine for Sedation in Parturients Undergoing Caesarean Section Under Spinal Anaesthesia?

Authors:  Andrea Cortegiani; Giuseppe Accurso; Cesare Gregoretti
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-10-01

2.  Maternal and preterm fetal sheep responses to dexmedetomidine.

Authors:  K Uemura; K Shimazutsu; R J McClaine; D J McClaine; R J Manson; W D White; P B Benni; J D Reynolds
Journal:  Int J Obstet Anesth       Date:  2012-08-28       Impact factor: 2.603

3.  Use of dexmedetomidine for pain control.

Authors:  Irina Grosu; Patricia Lavand'homme
Journal:  F1000 Med Rep       Date:  2010-12-17

4.  Dexmedetomidine: New avenues.

Authors:  Anju Grewal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

5.  Comparison of the Efficacy and Safety of Dexmedetomidine Administered in Two Different Modes Under Procedural Sedation and Analgesia in Plastic Surgery.

Authors:  Weipeng Xia; Shanshan Wang; Lingxin Wei; Xiaoming Deng; Dong Yang; Jinghu Sui; Juhui Liu
Journal:  Front Surg       Date:  2022-05-02

6.  Dexmedetomidine for an awake fiber-optic intubation of a parturient with Klippel-Feil syndrome, Type I Arnold Chiari malformation and status post released tethered spinal cord presenting for repeat cesarean section.

Authors:  Tanmay H Shah; Manasi S Badve; Kowe O Olajide; Havyn M Skorupan; Jonathan H Waters; Manuel C Vallejo
Journal:  Clin Pract       Date:  2011-07-01

7.  Intraoperative conditions and quality of postoperative analgesia after adding dexmedetomidine to epidural bupivacaine and fentanyl in elective cesarean section using combined spinal-epidural anesthesia.

Authors:  Samy Elsayed Hanoura; Rabei Hassanin; Rajvir Singh
Journal:  Anesth Essays Res       Date:  2013 May-Aug

Review 8.  Dexmedetomidine: an adjuvant making large inroads into clinical practice.

Authors:  Sj Bajwa; A Kulshrestha
Journal:  Ann Med Health Sci Res       Date:  2013-10

9.  Comparative Evaluation of Remifentanil and Dexmedetomidine in General Anesthesia for Cesarean Delivery.

Authors:  Chengwen Li; Yandong Li; Kun Wang; Xiangang Kong
Journal:  Med Sci Monit       Date:  2015-12-07

10.  Combination of dexmedetomidine and remifentanil for labor analgesia: A double-blinded, randomized, controlled study.

Authors:  Waleed Abdalla; Mona Ahmed Ammar; Ayman Ibrahim Tharwat
Journal:  Saudi J Anaesth       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.